Second generation STING agonist
Second generation STING agonist
Search
Triple agonist peptide
Triple agonist peptide
Phospholipid modulator
Phospholipid modulator
Vascular modulator
Vascular modulator
BI 764524: Sema3A antibody
BI 764524: Sema3A antibody
Oxidase Inhibitor
Oxidase Inhibitor
BI 1291583: CatC Inhibitor
BI 1291583: CatC Inhibitor
Modified yersinia
Modified yersinia
PD-1 antibody
PD-1 antibody
BI 1569912
BI 1569912
C3-binding polypeptide
C3-binding polypeptide
Anti-fibrotic agent
Anti-fibrotic agent
Ion channel inhibitor
Ion channel inhibitor
KRAS multi-inhibitor
KRAS multi-inhibitor
Immunomodulator
Immunomodulator
NPY2r agonist
NPY2r agonist
BI 765845: Heart disease modulator | Myocardial infarction
BI 765845: Heart disease modulator | Myocardial infarction
IL11 antibody
IL11 antibody
Lysophospholipase inhibitor
Lysophospholipase inhibitor
12th Expert Forum on Farm Animal Well-Being
The 12th Expert Forum on Farm Animal Well-Being brought together over 100 industry experts
Boehringer Ingelheim Venture Fund invests precision antimicrobials
Boehringer Ingelheim Venture Fund invests in the development of precision antimicrobials
Breathing hope: fighting the lung disease pulmonary fibrosis
The animation and accompanying article aims to draw attention to and raise awareness about pulmonary fibrosis, a disease often misdiagnosed an overlooked.
European_Commission_approves_nintedanibSSc-ILD
Nintedanib is approved as the first and only treatment of systemic sclerosis-associated interstitial lung disease
ArisGlobal acquires Boehringer Ingelheim technology
Boehringer Ingelheim’s signal analytics technology is acquired by ArisGlobal
Boehringer Ingelheim and Fraunhofer partnership
Boehringer Ingelheim and Fraunhofer IME launch collaboration which aims to develop sustainable animal health products